ChiCTR2500108412 版本V1.0 版本创建时间2025/08/29 14:41:29 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2500108412 

最近更新日期:

Date of Last Refreshed on:

2025-08-29 14:41:11 

注册时间:

Date of Registration:

2025-08-29 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

老年非心脏全麻手术患者苏醒期淡漠型谵妄与术后谵妄轨迹的关联:一项前瞻性队列研究

Public title:

Association Between hypoactive Emergence Delirium During Emergence and Postoperative Delirium Trajectory in Elderly Patients Undergoing Non-Cardiac Surgery Under General Anesthesia: A Prospective Cohort Study

注册题目简写:

English Acronym:

研究课题的正式科学名称:

老年非心脏全麻手术患者苏醒期淡漠型谵妄与术后谵妄轨迹的关联:一项前瞻性队列研究

Scientific title:

Association Between hypoactive Emergence Delirium During Emergence and Postoperative Delirium Trajectory in Elderly Patients Undergoing Non-Cardiac Surgery Under General Anesthesia: A Prospective Cohort Study

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

方正 

研究负责人:

程新琦,刘学胜 

Applicant:

Fang Zheng 

Study leader:

Cheng Xinqi, Liu Xuesheng  

申请注册联系人电话:

Applicant telephone:

+86 187 5657 6794

研究负责人电话:

Study leader's telephone:

+86 139 6501 5671

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

ay_founder@163.com

研究负责人电子邮件:

Study leader's E-mail:

ay_mz_cheng@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

安徽省合肥市蜀山区绩溪路218号

研究负责人通讯地址:

安徽省合肥市蜀山区绩溪路218号

Applicant address:

No. 218, Jixi Road, Shushan District, Hefei City, Anhui Province

Study leader's address:

No. 218, Jixi Road, Shushan District, Hefei City, Anhui Province

申请注册联系人邮政编码:

Applicant postcode:

230032

研究负责人邮政编码:

Study leader's postcode:

230032

申请人所在单位:

安徽医科大学第一附属医院

Applicant's institution:

The First Affiliated Hospital of Anhui Medical University

研究负责人所在单位:

安徽医科大学第一附属医院

Affiliation of the Leader:

The First Affiliated Hospital of Anhui Medical University

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

安医一附院科研伦审-PJ 2025-06-16

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

安徽医科大学第一附属医院临床研究伦理委员会

Name of the ethic committee:

The Clinical Research Ethics Committee of the First Affiliated Hospital of Anhui Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2025-08-01 00:00:00

伦理委员会联系人:

陈奕豪

Contact Name of the ethic committee:

Chen Yihao

伦理委员会联系地址:

安徽省合肥市蜀山区绩溪路218号

Contact Address of the ethic committee:

No. 218, Jixi Road, Shushan District, Hefei City, Anhui Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 551 6292 2234

伦理委员会联系人邮箱:

Contact email of the ethic committee:

c1hkylunli@163.com

研究实施负责(组长)单位:

安徽医科大学第一附属医院

Primary sponsor:

The First Affiliated Hospital of Anhui Medical University

研究实施负责(组长)单位地址:

安徽省合肥市蜀山区绩溪路218号

Primary sponsor's address:

No. 218, Jixi Road, Shushan District, Hefei City, Anhui Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

安徽省

市(区县):

合肥市

Country:

China

Province:

Anhui

City:

Hefei

单位(医院):

安徽医科大学第一附属医院

具体地址:

安徽省合肥市蜀山区绩溪路218号

Institution
hospital:

The First Affiliated Hospital of Anhui Medical University

Address:

No. 218, Jixi Road, Shushan District, Hefei City, Anhui Province

经费或物资来源:

国家自然科学基金

Source(s) of funding:

National Natural Science Foundation of China (NSFC)

Target disease:

hypoactive Emergence Delirium

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

主要目的:探讨苏醒期淡漠型谵妄是否独立预测老年患者术后谵妄的发生。 次要目的: (1)分析淡漠型ED与住院天数、术后并发症、认知结局的相关性; (2)探索淡漠型ED的危险因素。  

Objectives of Study:

Primary Aim: To investigate whether hypoactive emergence delirium during awakening independently predicts postoperative delirium in elderly patients. Secondary aims: (1) To analyze the correlation between hypoactive ED and hospital days, postoperative complications, and cognitive outcomes; (2) To explore risk factors for hypoactive ED.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

(1)签署知情同意书; (2)计划在全身麻醉下非心脏手术,手术时长>2小时; (3)年龄65-90岁; (4)全麻手术后进入麻醉后恢复室(PACU)的患者;

Inclusion criteria

(1) Signed informed consent; (2) Planned non-cardiac surgery under general anesthesia with a duration of >2 hours; (3) Age 65-90 years; (4) Patients admitted to the post-anesthesia recovery unit (PACU) after surgery under general anesthesia;

排除标准:

(1)有精神病史或神经系统疾病史(包括抑郁症、严重的中枢神经系统抑郁症、精神分裂症、癫痫、帕金森病或阿尔茨海默病); (2)术前确诊严重痴呆或无法沟通; (3)曾使用精神药物或阿片类药物,术前曾有谵妄病史; (4)术后转入ICU患者; (5)神经外科以及心脏外科手术患者;

Exclusion criteria:

(1) History of psychiatric or neurologic disorders (including depression, severe central nervous system depression, schizophrenia, epilepsy, Parkinson's disease, or Alzheimer's disease); (2) Preoperative diagnosis of severe dementia or inability to communicate; (3) Previous use of psychotropic or opioid medications and preoperative history of delirium; (4) Patients transferred to the ICU after surgery; (5) Neurosurgery as well as cardiac surgery patients;

研究实施时间:

Study execute time:

From 2025-08-01 00:00:00 To 2025-12-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-08-01 00:00:00 To 2025-12-01 00:00:00  

干预措施:

Interventions:

组别:

Case series

样本量:

498

Group:

Case series

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

安徽省 

市(区县):

合肥市 

Country:

China 

Province:

Anhui 

City:

Hefei 

单位(医院):

安徽医科大学第一附属医院 

单位级别:

三甲 

Institution
hospital:

The First Affiliated Hospital of Anhui Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

术后谵妄发生率

指标类型:

主要指标

Outcome:

Postoperative Delirium, POD

Type:

Primary indicator

测量时间点:

术后5天

测量方法:

Measure time point of outcome:

5 days after surgery

Measure method:

指标中文名:

术后谵妄累计发生率

指标类型:

次要指标

Outcome:

Cumulative incidence of postoperative delirium

Type:

Secondary indicator

测量时间点:

术后5天内

测量方法:

3D-CAM

Measure time point of outcome:

5 days after surgery

Measure method:

3D-CAM

指标中文名:

术后苏醒期淡漠型谵妄发生率

指标类型:

次要指标

Outcome:

Incidence of indifferent delirium during postoperative awakening

Type:

Secondary indicator

测量时间点:

术后转入PACU30mins

测量方法:

Measure time point of outcome:

Postoperative transfer to PACU for 30 minutes

Measure method:

指标中文名:

术中各种麻醉药物剂量

指标类型:

次要指标

Outcome:

Dosage of various anesthetic drugs during surgery

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

麻醉时间

指标类型:

次要指标

Outcome:

Anesthesia time

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

手术时间

指标类型:

次要指标

Outcome:

Operation time

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术前和术后各项生化、血常规指标

指标类型:

次要指标

Outcome:

Biochemical and blood routine indicators before and after surgery

Type:

Secondary indicator

测量时间点:

术前和术后第1天

测量方法:

Measure time point of outcome:

Day 1 before and after surgery

Measure method:

指标中文名:

术后苏醒期认知维度评分

指标类型:

次要指标

Outcome:

Cognitive dimension score during postoperative awakening

Type:

Secondary indicator

测量时间点:

术后苏醒期

测量方法:

MMSE评分

Measure time point of outcome:

Postoperative awakening period

Measure method:

指标中文名:

术后认知维度评分

指标类型:

次要指标

Outcome:

Postoperative cognitive dimension score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

手术类型

指标类型:

次要指标

Outcome:

Type of surgery

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术中液体使用情况

指标类型:

次要指标

Outcome:

Intraoperative fluid usage

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 65 years
最大 Max age 90 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

None

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

论文发表后通过通讯作者邮箱共享

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

The original data wil be shared through the corresponding author's email after publication

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2025-08-29 14:41:11